使用微型CT对喘小鼠肺部进行定量形态测量分析:一个临床前成像研究
Lam Hoang Bao Nguyen1, Juwan Kim2, Ngan-Khanh Chau3
1School of Mechanical Engineering and IEDT, Kyungpook National University, Daegu, Republic of Korea.
Respiratory physiology & neurobiology
|January 30, 2026
概括
这项研究使用了小鼠的微型CT扫描来区分异性喘 (EOS) 和中性喘 (NEU). 定量成像揭示了每个喘表型的呼吸道和肺部的独特结构变化,有助于向治疗的开发.
科学领域:
- 肺部医学 肺部医学
- 医疗成像医学成像
- 临床前研究 临床前研究
背景情况:
- 喘是一种复杂的疾病,具有明显的eosinophilic (EOS) 和neutrophilic (NEU) 炎症表型.
- 这些表型呈现出独特的呼吸道和辅酶体结构变化,在人类研究中难以表征.
- 鼠类模型提供了一个受控的环境来研究表型特定的病理变化.
研究的目的:
- 在小鼠模型中使用高分辨率微型计算机断层扫描 (micro-CT) 探索和区分EOS和NEU喘的表型特异性结构和密度度变化.
- 为了将成像发现与炎症内型和组织病理学相关联.
- 支持非侵入性临床前表型化和向疗法的开发.
主要方法:
- 16只雌性C57BL/6NCrlOri小鼠被分配到对照组,EOS喘组或NEU喘组.
- 使用高分辨率的微型CT,用Hounsfield单位值量化气道形态学 (分叉角度,圆形,液压直径,壁厚,光体积) 和膜变化 (瘤样变化,地面玻璃不透明,巩固,纤维化).
- 进行了支气管支气管洗 (BAL) 流动细胞计和肺组织病理学,以确认炎症内型和组织重塑.
主要成果:
- 在EOS喘中,偏远气道和主要支气管的改变占主导地位,循环度和液压直径增加,地面玻璃的不透明度和半凝固度更高.
- NEU喘表现出广泛的近道气道扩张与增加的光体积,但最小的辅酶体变化.
- 气管参数与GGO和半巩固正相关. BAL证实了EOS中的乙氨基缩和NEU中的中性粒细胞/单细胞增加. 组织病理学揭示了NEU小鼠中较大的周围支气管炎症和重塑.
结论:
- 定量微CT有效地区分EOS和NEU喘表型,通过在临床前模型中捕捉不同的气道和体结构和密度学特征.
- 这些发现支持微型CT用于非侵入性喘临床前表型的使用.
- 这种方法可以促进开发和测试表型向喘治疗策略.
相关概念视频
Imaging Studies I: CT and MRI
876
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
876
Imaging Studies for Cardiovascular System V: CT
361
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
361
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
485
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
485
Quantitative Analysis
1.4K
Quantitative analysis is a technique for measuring the amount of specific constituents in a sample. When the sample's composition is unknown, qualitative analysis is performed first to identify its components, which ensures that the correct substances are measured during the quantitative phase.
In quantitative analysis, two key measurements are made: the sample quantity and a property proportional to the amount of the analyte (the substance being analyzed). This forms the basis of the...
In quantitative analysis, two key measurements are made: the sample quantity and a property proportional to the amount of the analyte (the substance being analyzed). This forms the basis of the...
1.4K
Lung Capacity
56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Preclinical Development: Overview
6.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.0K


